NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Revolution Medicines

Revolution Medicines

Public
Redwood City, CaliforniaBiotechhttps://www.revmed.com/

Revolution Medicines is now publicly traded

The data on this page reflects Revolution Medicines's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Feb 18, 2020

Last Round

Follow-on Offering

Apr 17, 2026

Est. Valuation at Exit

$29.7B

Total Funding Raised

$2.97B

Company Overview

Revolution Medicines is a clinical-stage precision oncology company that develops novel targeted therapies for RAS-addicted cancers.

Sector

Biotech

AI Layer

Infrastructure

Keywords

precision oncologyRAS inhibitorstargeted cancer therapydrug discovery platformsmall-molecule inhibitorsRAS-mutated cancerbiotechclinical-stage biotechcomputational drug discoveryAI drug discoverypancreatic cancer treatmentoncology pipelinein silico drug designpharma R&DAI-first biotech

Revolution Medicines Comparables

Compare Revolution Medicines with similar companies based on industry and business-model similarity.

Revolution Medicines comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Revolution Medicines Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingApr 17, 2026
Convertible DebtApr 17, 2026
Corporate FundingJun 24, 2025
IPOFeb 18, 2020
Series CJul 9, 2019
Series B
Apr 24, 2018

Key People

Founding team and executive leadership

Peg Horn

Chief Operating Officer

Executive Team

Revolution Medicines Investors

Notable investors and investment history

Revolution Medicines investors
InvestorRounds
The Column GroupSeries C, Series A Extension, Series B
Deerfield ManagementSeries C
Boxer CapitalSeries C
Guggenheim SecuritiesIPO
Cormorant Asset ManagementSeries C
Fidelity Management & Research CompanySeries C
Royalty PharmaCorporate Funding

Revolution Medicines Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Revolution Medicines Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersRedwood City, California
Employee Range949
Year Founded2014
Last FundingApr 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.